Ц.Билэгтсайхан
Loading...
Товч нэр
Ц.Билэгтсайхан
Бүтэн нэр
Цолмон Билэгтсайхан
Латин нэр
Tsolmon Bilegtsaikhan
Албан тушаал
Проректор
Эрдмийн цол
Дэд профессор
Боловсролын зэрэг
Доктор (Ph.D)
ORCID
Scopus Author ID
37 results
Now showing 1 - 10 of 37
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Impact of Pneumococcal Conjugate Vaccine Introduction on Pneumonia Incidence Rates in Children 2-59 Months of Age in Mongolia, 2015-2021: Population-Based Surveillance(2023) ;von Mollendorf, C. ;Ulziibayar, M. ;Nguyen, C.D. ;Batsaikhan, P.Suuri, B. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Immunogenicity, Safety, and Reactogenicity of a Half- Versus Full-Dose BNT162b2 (Pfizer-Biontech) Booster Following a Two-Dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac Priming Schedule in Mongolia: A Randomised, Controlled, Non-Inferiority Trial(Elsevier BV, 2023) ;Batmunkh, Tsetsegsaikhan ;Moore, Kerryn ;Thomson, Helen ;Altangerel, BolorAmraa, Otgonjargal - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Additional file 1 of Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019–2022)(Figshare (United Kingdom), 2025-01-01) ;Mungun, Tuya ;Ulziibayar, Munkhchuluun ;Nguyen, Cattram D. ;Batsaikhan, PurevsurenSuuri, Bujinlkham - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Additional file 1 of Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019–2022)(Figshare (United Kingdom), 2025-01-01) ;Mungun, Tuya ;Ulziibayar, Munkhchuluun ;Nguyen, Cattram D. ;Batsaikhan, PurevsurenSuuri, Bujinlkham - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Additional file 1 of Factors associated with severe pneumonia in adults hospitalised with community-acquired pneumonia in Mongolia(Figshare (United Kingdom), 2026-01-01) ;Amy Simkiss ;Munkhchuluun Ulziibayar ;Purevsuren Batsaikhan ;Bujinlkham SuuriDashtseren LuvsantserenSupplementary Material 1: Supplementary Table 1. Describes demographic characteristics and risk factors with multiple categories in adults hospitalised with clinical community acquired pneumonia by severity status. The data in this table expands upon the binary categories used for these variables in Table 1. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019-2022)(2025-11) ;Mungun, Tuya ;Ulziibayar, Munkhchuluun ;Nguyen, Cattram D ;Batsaikhan, PurevsurenSuuri, BujinlkhamBACKGROUND: Streptococcus pneumoniae is an important cause of pneumonia in older adults, however, serotyping and indirect impact information from low and middle-income countries is lacking. Mongolia has a childhood 13-valent pneumococcal conjugate vaccine (PCV13) program, but no adult pneumococcal vaccination program. We describe pneumococcal carriage rates, disease and serotype distribution among adults hospitalised with pneumonia, and explore changes over the COVID-19 pandemic period. METHODS: Adults (≥ 18 years) hospitalised with clinical pneumonia were enrolled over 3 years (March 2019-February 2022) into a prospective pneumonia surveillance program. Nasopharyngeal swabs were tested to detect pneumococci using lytA qPCR and molecular serotyping by DNA microarray and metagenomics. Pneumococcal pneumonia was identified using serotype-specific urinary antigen detection and BinaxNOW® assays. Pneumococcal carriage and pneumonia prevalence were assessed over the COVID-19 period with log-binomial regression used to estimate prevalence and adjusted prevalence ratios (pre- versus early- and late-COVID-19 periods). RESULTS: Of 3,178 pneumonia cases, S. pneumoniae was identified in 12.1% (333/2,759) of swabs and 8.6% (253/2,925) of urine samples. PCV13 serotype carriage prevalence was 3.1% (82/2,663) and non-PCV13 serotype carriage prevalence 5.7% (152/2,663). In the late-COVID-19 period, pneumococcal carriage prevalence was reduced by 66% (aPR 0.34, 95%CI 0.25-0.46) and pneumococcal pneumonia by 82% (aPR 0.18, 95%CI 0.12-0.27) compared with the pre-COVID-19 transmission period. CONCLUSION: Despite paediatric vaccination with high coverage, we identified some residual PCV13 serotypes with predominance of non-PCV13 serotypes carried and causing disease in adults. Direct adult vaccination which targets these serotypes will potentially reduce disease in adults in Mongolia. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Association between quantitative computed tomography metrics and pulmonary function in patients with post-COVID-19 pulmonary fibrosis: a single-center cross-sectional study(Springer Science and Business Media LLC, 2026-08-26) ;Bayaraa, Odonchimeg; ;Galbadrakh, Ninjbadgar ;Bayarsaikhan, Dalai - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Changes in Pneumococcal Carriage in Hospitalised Children 2-59 Months of Age in Mongolia Following Pneumococcal Conjugate Vaccine Introduction(Elsevier BV, 2023) ;von Mollendorf, Claire ;Mungun, Tuya ;Ulziibayar, Munkhchuluun ;Nguyen, Cattram D.Batsaikhan, Purevsuren - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Association between prostate cancer development and TARBP1(Mongolian National University of Medical Sciences, 2025-03-31); ; ; ; Objective: Prostate cancer is the most frequent cancer among elderly men worldwide and second cause of cancer-related deaths in man. Prostate cancer characterized a clinically heterogeneous and genetic alterations in cells play a pivotal role in carcinogenesis. A detailed understandings of the genetic alterations in cancer cells are important for developing new therapeutic medicine. Transactivation response RNA-binding protein1 (TARBP1) encodes a protein with RNA-binding, tRNA methyltransferase activity, and RNA interference regulation functions, but its association with prostate cancer remains unclear. The aim of this study was to investigate clinical significance of TARBP1 in prostate cancer. Methods: Relative messenger ribonucleic acid (mRNA) and protein expression of TARBP1 in prostate cancer cell and tumor tissue was determined by qRT-PCR and Western blot analysis. LNCaP cells with lentivirus vector to silence the expression of TARBP1 were injected into nude mice. After 24 days, the mice were killed and tumor tissues were excised. The size of tumors was measured using a ruler and body weight of mice were weighed using a scale. Results: Through qRT-PCR and Western blot analysis, we validated that the expression levels of TARBP1 was decreased in TARBP1-knockdown prostate cancer cell compared with cells transfected with negative control LV-shNC RNA. The tumor growths were significant smaller in the group B (LNCaP-LV-shTARBP1) compared with group A (LNCaP-LV-shNC). Knocking down TARBP1 significantly suppressed the tumor progression of BALB/C nude xenograft. Moreover, body weight of mice in LNCaP-LV-shNC group increased significant slowly compared with LNCaP-LV-shTARBP1 group. The result of western blot analysis for TARBP1 in tumor tissues from xenograft nude mice bearing orthotopic LNCaP tumors shows that the expression of TARBP1 was also significantly decreased in the LNCaP-LV-shTARBP1 group compared with LNCaP-LV-shNC group (p < 0.05). Conclusion: We revealed that the TARBP1 highly expressed in prostate cancer and its role in promoting tumor growth. TARBP1 could serve as a potential therapeutic target for prostate cancer treatment and it is also a biomarker for tumor diagnosis and prognosis. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Additional file 1 of Factors associated with severe pneumonia in adults hospitalised with community-acquired pneumonia in Mongolia(Figshare (United Kingdom), 2026-01-01) ;Amy Simkiss ;Munkhchuluun Ulziibayar ;Purevsuren Batsaikhan ;Bujinlkham SuuriDashtseren LuvsantserenSupplementary Material 1: Supplementary Table 1. Describes demographic characteristics and risk factors with multiple categories in adults hospitalised with clinical community acquired pneumonia by severity status. The data in this table expands upon the binary categories used for these variables in Table 1.
